Impedimed

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Trading Performance

Commodity Channel Index

Score

-0.1

Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 52 8.3 0.42% 0.67% 5.5% -6.0% -76.8%
SHORT 52 7.9 0.65% 1.62% 5.9% -6.6% 60.5%

Summary

Technical Analysis

Impedimed (IPD.AX)


Indicator:

COMMOIDITY CHANNEL INDEX


Last Signal:

BEARISH


Trading: SELL @ $0.115
Signal Strength: MEDIUM
Recommendation:

Impedimed (ASX:IPD) current trading has maintained the Commodity Channel Index to overbought status and signalled the continuation of the bearish trading conditions. Currently, the CCI is -76. The bearish signal has been active for 32 days. During the quarter, the highest CCI value was 375.


Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading exit. Indicator can be applied to the short/medium term timeframe, but the best results are obtained with larger cyclical swings in-line with the trend direction. This accumulation / distribution oscillator can provide guidance on the money flow direction from the companies recent trading.


The Commodity Channel Index indicator takes a security’s change in price and compares that to its average change in price. CCIs calculation produces positive and negative values that oscillate above and below a Zero Line. Typically a value of 100 is identified as overbought and a reading of -100 is identified as being oversold.

Calculation: 20 Period CCI:
1) CCI = (Typical Price - 20 Period SMA of TP) / (.015 x Mean Deviation);
2) Typical Price (TP) = (High + Low + Close)/3;


PROFILE: Impedimed (IPD.AX)


Stock Exchange: ASX
Company: Impedimed
Ticker Codes: | IPD.AX | ASX:IPD |

About Impedimed (ASX:IPD):

ImpediMed Limited, together with its subsidiaries, engages in the development, manufacture, and sale of bioimpedance devices and consumables in Australia, North America, Europe, and internationally. The company operates through Medical and Test & Measurement segments. It offers L-Dex U400, a technology that utilizes the characteristics of frequency dependent current flow to quantify changes in extracellular fluid in the patient's limb; and SFB7, a tetra polar bioimpedance spectroscopy device that scans various frequencies for the estimation of body composition in healthy individuals. The company also provides DF50, a single frequency body composition analysis in healthy individuals; and ImpediVET, a bioimpedance spectroscopy technology for use in veterinary applications. Its products are used in a range of applications, such as in the assessment and monitoring of secondary lymphedema, as well as monitoring of body composition and hydration. In addition, the company is involved in the supply of power precision testing and measuring equipment. ImpediMed Limited was founded in 1999 and is headquartered in Pinkenba, Australia.

Top 10:

Commodity Channel Index

Download
Company Close Change(%) Volume Value Signal
AJX Alexium International 0.13 13 328,122 -24 BEARISH
BOC Bougainville Copper 0.11 10 84,981 -45 BEARISH
MGX Mount Gibson Iron 1.06 9.3 5,320,324 -73 BEARISH
CAJ Capitol Health 0.22 7.3 466,982 -111 BEARISH
MNF My Net Fone 3.73 7.2 55,752 -59 BEARISH
GNG GR Engineering Services 0.85 5.6 43,068 -108 BEARISH
IDX Integral Diagnostics 3.04 4.8 42,581 -35 BEARISH
BFC Beston Global Food 0.11 4.8 118,825 -103 BEARISH
PGH Pact 2.38 4.8 1,550,238 -11 BEARISH
REG Rg Capital Radio 2.71 4.2 646,566 -49 BEARISH